By keeping issuance disciplined, the BoT ensures that lower policy rates do not trigger excessive liquidity growth that could ...

Vertex International Securities Ltd is targeting to raise Sh10 billion as it launches two pioneering products set to reshape Tanzania’s capital markets.The two products are the Vertex International ...

Vertex Pharmaceuticals on Monday reported disappointing first-quarter earnings impacted by weaker-than-expected sales of its drugs for cystic fibrosis, and little or no contributions from a gene ...

Vertex Pharmaceuticals' non-opioid painkiller significantly decreased pain in patients with diabetes suffering from chronic nerve pain in a mid-stage trial, fueling efforts to develop a treatment ...

Vertex is faced with an access challenge as it is charging $15.50 for a 50 mg dose of Journavx, which works out to $420 for a two-week course. Generic opioids, meanwhile, go for roughly $0.50 a pill.